Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.31 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 4/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.30 |
| ▸ | HTT | P42858 | 3/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6710016 | 0.89 | LMNA (0.36) | LMNACYP1A2HIF1AMEN1KMT2A | |
| SCHEMBL7129851 | 0.89 | LMNA (0.36) | LMNACYP1A2HIF1AMEN1KMT2A | |
| SCHEMBL6709076 | 0.88 | LMNA (0.35) | LMNACYP1A2HIF1AMEN1KMT2A | |
| SCHEMBL6710262 | 0.87 | HIF1A (0.42) | LMNACYP1A2HIF1AMEN1KMT2A | |
| SCHEMBL6833135 | 0.85 | KCNK2 (0.40) | LMNACYP1A2HIF1AMEN1KMT2A | |
| Sulfuric Acid SCHEMBL6834053 | 0.82 | KCNK2 (0.38) | LMNACYP1A2HIF1AMEN1KMT2A | |
| SCHEMBL6753986 | 0.81 | RORC (0.32) | RORCMAPTTP53 | |
| SCHEMBL6710332 | 0.78 | EPHX2 (0.39) | HIF1AMEN1KMT2AMAPTHTT | |
| SCHEMBL6710378 | 0.78 | SMN1; SMN2 (0.35) | HIF1AMEN1KMT2AMAPTHTT | |
| SCHEMBL6710398 | 0.77 | LMNA (0.37) | LMNACYP1A2HIF1AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | LMNA 4062/4885CYP1A2 492/4885HIF1A 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.